Spyre Announces Potential Best-in-Class SPY003 (anti-IL-23) Part A Induction Results from SKYLINE Trial, Completing Proof-of-Concept for All Three Components of its IBD Combinations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| (NASDAQ: SYRE) | Delayed: 92.95 +1.55 (1.70%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $91.40 | 52 Week High | $ | |||
| Open | $92.78 | 52 Week Low | $ | |||
| Day High | $95.17 | P/E | N/A | |||
| Day Low | $92.32 | EPS | $ | |||
| Volume | 1,153,116 | |||||
